tiprankstipranks
Trending News
More News >
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market

Cardiol Therapeutics (CRDL) Financial Statements

Compare
168 Followers

Cardiol Therapeutics Financial Overview

Cardiol Therapeutics's market cap is currently $163.65M. The company's EPS TTM is C$-0.1; its P/E ratio is ―; Cardiol Therapeutics is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is C$-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 78.76KC$ 0.00
Gross ProfitC$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76KC$ -229.54K
Operating IncomeC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47MC$ -20.61M
EBITDAC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44MC$ -20.41M
Net IncomeC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72MC$ -20.65M
Balance Sheet
Cash & Short-Term InvestmentsC$ 30.58MC$ 34.93MC$ 59.47MC$ 83.90MC$ 14.03M
Total AssetsC$ 31.86MC$ 36.70MC$ 62.03MC$ 87.88MC$ 15.89M
Total DebtC$ 158.53KC$ 158.53KC$ 72.87KC$ 117.58KC$ 156.57K
Net DebtC$ -30.42MC$ -34.77MC$ -59.40MC$ -83.78MC$ -13.87M
Total LiabilitiesC$ 7.14MC$ 8.45MC$ 9.83MC$ 11.64MC$ 2.62M
Stockholders' EquityC$ 24.73MC$ 28.25MC$ 52.20MC$ 76.24MC$ 13.27M
Cash Flow
Free Cash FlowC$ -25.08M-C$ -27.30MC$ -23.56MC$ -9.23M
Operating Cash FlowC$ -25.06M-C$ -27.22MC$ -23.55MC$ -9.19M
Investing Cash FlowC$ -21.29KC$ -64.31KC$ -74.71KC$ -12.92KC$ -40.60K
Financing Cash FlowC$ 18.84M-C$ -53.93KC$ 93.44MC$ 16.30M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Cardiol Therapeutics Debt to Assets

Cardiol Therapeutics Cash Flow

Cardiol Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis